An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants

Completed · Phase 1

Conditions studied: Psoriasis

In brief

This is an investigational study of Cyclosporine on the experimental medication BMS-986165 in healthy male participants.

Key facts

Study ID

NCT03419910

Run by

Bristol-Myers Squibb

People needed

54

Starts

2018-03-05

Expected to finish

2018-05-04

Last updated by the study team

2020-03-18

Who can join

Age: 18 and older, up to 50. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Healthy participant, as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations
• Body mass index 18.0 to 32.0 kg/m2
• Weight ≥ 50 kg

You may not qualify if…

• Any medical condition that presents a potential risk to the subject and/or may compromise the objectives of the study, including a history of or active liver disease
• History or presence of acute or chronic bacterial, fungal, or viral infection (eg, pneumonia, septicemia) within the 3 months prior to screening
• Known or suspected autoimmune disorder, or any history of known or suspected congenital or acquired immunodeficiency state or condition that would compromise the participant's immune status
• History of administration of live vaccines within 60 days before screening
• Any history or risk for tuberculosis (TB)
• Other protocol defined inclusion/exclusion criteria could apply

Where it is running

• PRA Health Sciences — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.